BeiBangAn
Ordered peptides from BeiBangAn? Mail in a sample (US only) and let us test it.
Test my supplyBeiBangAn's stronger evidence is in GHK-Cu, where identity and high-purity results recovered after an early fill miss, while Tirzepatide is mixed but has several passing identity checks. Retatrutide drives most volatility with repeated purity misses, BPC-157 is thin, and missing batch IDs limit confidence despite recent volume.
Corporate records, forum archives, and web assets point to a short-lived Telegram storefront with SigmaAudley/AkumaRift continuity, not a mature manufacturer. The full dossier maps the LNPeptide overlap, domain trail, payment/contact rails, and unresolved Hong Kong company lead.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including BeiBangAn rows.
Cancel anytime
Ordered peptides from BeiBangAn? Mail in a sample (US only) and let us test it.
Test my supply| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
21 Aug 2026 | Pass | Retatrutide BeiBangAn | lab name | View COA | |||
18 Aug 2026 | Pass | Tirzepatide BeiBangAn | lab name | View COA | |||
18 Aug 2026 | Pass | Retatrutide BeiBangAn | lab name | View COA | |||
18 Aug 2026 | Pass | Semaglutide BeiBangAn | lab name | View COA | |||
4 Aug 2026 | Pass | Tirzepatide BeiBangAn | lab name | View COA | |||
21 Jul 2026 | Pass | Tirzepatide BeiBangAn | lab name | View COA | |||
13 Jul 2026 | Pass | Tirzepatide BeiBangAn | lab name | View COA | |||
13 Jul 2026 | Pass | GHK-Cu BeiBangAn | lab name | View COA | |||
10 Jul 2026 | Pass | Retatrutide BeiBangAn | lab name | View COA | |||
26 Jun 2026 | Pass | Retatrutide BeiBangAn | lab name | View COA | |||
About BeiBangAn test results from Finnrick
BeiBangAn is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 63 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible BeiBangAn peptides in this dataset are BPC-157 (4 tests), GHK-Cu (5 tests) and Retatrutide (34 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 63 recent tests. It also includes 1 correction related to this vendor.
Ordered peptides from BeiBangAn? Mail in a sample (US only) and let us test it.
Test my supply